Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia (EPICOR ASIA)
This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
First received: May 23, 2011
Last updated: September 23, 2013
Last verified: September 2013
The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.
||Observational Model: Cohort
Time Perspective: Prospective
||Long-Term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia
Primary Outcome Measures:
- short- and long-term medication and treatment prescribed by physicians in real-life setting [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- clinical outcome (Cardiovascular events) [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
- cost of hospitalization [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
- quality of life (EQ-5D questionnaire) [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||March 2014 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Asian patients hospitalized for ACS within 48 hours of symptom onset and who have a final diagnosis of unstable angina (UA), STEMI or non-ST-segment elevation myocardial infarction (NSTEMI).
- Written informed consent has been provided.
- Diagnosis of STEMI, NSTEMI or UA
- Hospitalization for the first time within 48 hours of onset of symptoms.
- UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons.
- Current participation in a randomised interventional clinical trial.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01361386
||Prof. Huo Yong
||Peking University 1st Hospital
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||May 23, 2011
||September 23, 2013
||Vietnam: Ministry of Health
Keywords provided by AstraZeneca:
Long-term follow up
Antithrombotic management patterns
Acute Coronary Syndrome
quality of life
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on December 11, 2013
Acute Coronary Syndrome
Signs and Symptoms